Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02338109

Ligand	Ligand name	Chain	PDB	Tanimoto
ATI	N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID	A	1Y0Y	0.7
BB2	ACTINONIN	A,B,C,D	3G5K	0.71
BB2	ACTINONIN	A,B,C	1LRU	0.71
BB2	ACTINONIN	A,B	2OKL	0.71
BB2	ACTINONIN	A	2OS1	0.71
BB2	ACTINONIN	A,B,C	1G2A	0.71
BB2	ACTINONIN	A	1Q1Y	0.71
BB2	ACTINONIN	A,B,C,D,E,F,G,H	1SZZ	0.71
BB2	ACTINONIN	A	1LQY	0.71
BB2	ACTINONIN	A	2OS3	0.71
BB2	ACTINONIN	A	1LRY	0.71
BB2	ACTINONIN	A,B	1IX1	0.71
BB2	ACTINONIN	A	1WS1	0.71
OCQ	(3S)-3-[(2S)-2-AMINO-4-HYDROXY-3-OXOBUTYL]PYRROLIDIN-2-ONE	A,I	2Z3D	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	B	1GNO	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	B	1A9M	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1AXA	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1GNM	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1GNN	0.71
IVS	3-HYDROXY-6-METHYL-4-(3-METHYL-2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER	A,B	1ME6	0.71
QGA	1-[(3-CYCLOHEXYLPROPANOYL)(2-HYDROXYETHYL)AMINO]-1-DEOXY-D-ALLITOL	A,B	2JGQ	0.71
U17	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]-L-SERYL-L-LEUCINATE	A	2GGB	0.74
AR9	(2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,15-dioxo-1,4-diazacyclopentadecan-5-yl]-4-hydroxy-2-methylbutanamide	A,B,C	3DV1	0.8
097	(2S,3R)-N~4~-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide	A,B	3HY7	0.73
097	(2S,3R)-N~4~-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide	A,B	2JIH	0.73
097	(2S,3R)-N~4~-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide	A	1R55	0.73
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	3EMY	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	2H6T	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1LS5	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1SME	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,C	1W6I	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1XDH	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	2QZX	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	1IZE	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1M43	0.71
TMD	(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE	C	1CWK	0.72
AHS	(3-AMINO-4-CYCLOHEXYL-2-HYDROXY-BUTYL)-ISOBUTYL-CARBAMIC ACID	I	5ER2	0.78
REY	GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL-D-ALANINE	A	1IKI	0.7
FEB	N~2~-[(3R)-3-hydroxydodecanoyl]-L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-L-glutamamide	2,H,K,N,V,Y	3D29	0.74
ECQ	(3S)-3-[(2S)-2-AMINO-3-HYDROXYBUTYL]PYRROLIDIN-2-ONE	A,I	2Z3D	0.75
CHK	6-[(CYCLOHEXYLACETYL)(2-HYDROXYETHYL)AMINO]-6-DEOXY-D-XYLO-HEXITOL	B	1Y01	0.72